Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2/3 Prospective, Multicentre Randomized, Double-blind Trial, Comparing Intra-discal Allogeneic Adult BM-MSC Therapy and Sham-treated Controls in Subjects With Chronic LBP Due to Lumbar DDD Unresponsive to Conventional Therapy

NCT03737461 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03737461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03737461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2/3 Prospective, Multicentre Randomized, Double-blind Trial, Comparing Intra-discal Allogeneic Adult BM-MSC Therapy and Sham-treated Controls in Subjects With Chronic LBP Due to Lumbar DDD Unresponsive to Conventional Therapy
Lead sponsor
University Hospital, Montpellier
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
February 18, 2019
Completion date
March 8, 2026
Enrollment
113 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease (ddd), recurrent low back pain